State-of-the-art 3T MRI and cutting-edge molecular imaging are fully integrated as one. Only Siemens makes the simultaneous acquisition of whole-body MR and PET possible. Molecular MR supports our ...

Swiss drugmaker Novartis (NOVN.S), opens new tab said on Saturday it had received a binding offer from Germany's Siemens Healthineers (SHLG.DE), opens new tab to acquire its molecular imaging ...

Novartis noted that a dedicated diagnostics owner would better support molecular imaging's growth prospects, leading to this ...

“The number of patients suffering from cancer and neurodegeneration is rising rapidly as life expectancies increase,” said Jim Williams, Siemens Healthineers’ head of molecular imaging.

Novartis confirmed that it has received a binding offer from Siemens Healthineers to buy its molecular imaging business for an undisclosed amount. The Swiss pharma major said Monday that the ...

The deal, which a Siemens spokesperson confirmed via email, includes the manufacturing and distribution network of Advanced Accelerator Applications (AAA) Molecular Imaging. Novartis acquired AAA ...

Siemens is the largest global manufacturer of MR, CT, X-ray, and molecular imaging. In the advanced therapies segment, the firm holds a top market position in hybrid operating rooms and ...

Siemens Healthineers has agreed to buy part ... of the business — after concluding that “the growth of the molecular imaging business would be best supported under the ownership of a dedicated ...

(Reuters) -Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany's Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission ...